Privi Speciality Chemicals logo

Privi Speciality Chemicals

PRIVISCL NSE

Key Fundamentals

MicrocapSpecialty ChemicalsChemicals
Market Cap
₹13,905 Cr
Volatility
Moderate
P/E Ratio
39.94
EBITDA
₹666 Cr
Return on Equity
21.99%
Debt to Equity
0.72
Book Value
₹361.58
EPS
₹31.14
52W High
₹3,785.3
52W Low
₹2,345.3

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has delivered good profit growth of 26.8% CAGR over last 5 years

Weaknesses

2
  • Stock is trading at 9.89 times its book value
  • Promoter holding has decreased over last 3 years: -13.4%

Growth Rate

Revenue Growth
21.73% higher than 3Y
Net Income Growth
71.37% lower than 3Y
Cash Flow Change
95.68% higher than 3Y
ROE
33.03% higher than 3Y
ROCE
23.69% lower than 3Y
EBITDA Margin (Avg.)
15.26% lower than 3Y

AI Analysis — Bull vs Bear

4d ago
AI opinion · based on fundamentals
Risk high

Privi Speciality Chemicals has a market cap of about ₹14,102 crore and trades at a P/E of 41.1 and a P/B of 9.94. Growth has picked up recently: TTM sales are up 22% and TTM profit is up 61%, and ROE rose to 26% last year from a 5-year and 10-year average of 15%. The valuation is high, the dividend yield is 0.28%, and promoter holding has fallen by 13.4% over the last three years.

Bull Case 7
  • Profit has grown at a 26.8% CAGR over the last 5 years, well ahead of 5-year sales growth of 15%. That points to margin expansion and operating leverage.
  • Growth sped up in the trailing twelve months. TTM profit growth of 61% and TTM sales growth of 22% are both above the company's 5-year CAGRs of 27% and 15%.
  • ROE rose to 26% last year from a 3-year average of 19% and a 5-year average of 15%, so returns on shareholder capital have improved.
  • 3-year compounded profit growth of 144% shows a sharp earnings recovery. Recent profit growth has far outpaced the 17% 3-year sales CAGR.
  • Sales have compounded at 15-17% over both the 3-year and 5-year periods, and TTM sales growth is 22%. Top-line growth has been steady and is getting faster.
  • The stock's 10-year CAGR of 27% and 3-year CAGR of 43% show that shareholders have been rewarded over the long term.
  • Dividing P/B of 9.94 by P/E of 41.1 gives an implied ROE of about 24%, which matches the reported 26% ROE. The earnings growth is feeding through to returns on book value.
Bear Case 8
  • The stock trades at 9.94 times book value. That is a steep premium for a chemicals business, and it leaves little room for any earnings disappointment.
  • A P/E of 41.1 means an earnings yield of about 2.4%. The valuation already assumes strong growth will continue.
  • Promoter holding has fallen by 13.4% over the last three years. Some investors may read that as a governance or alignment concern.
  • ROE averaged only 15% over both the 5-year and 10-year periods, well below last year's 26%. This suggests returns are cyclical and the current level may not last.
  • The 144% 3-year profit CAGR likely comes off a depressed base. Past earnings have been volatile, which makes recent growth rates a poor guide to the long-term trend.
  • The stock is up 52% in the past year and has a 3-year CAGR of 43%. Much of the recent earnings recovery may already be in the price.
  • The dividend yield is 0.28%, which offers little income support if the valuation compresses.
  • The data provided does not include debt-to-equity or ROCE. Balance-sheet leverage in a capital-intensive chemicals business can't be checked from this data.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago
Headwinds 1
  • SBI MF trims stake slightly Sep 25

    SBI Mutual Fund sold 18,400 shares of Privi Speciality on September 24, 2026, bringing its holding down to 7.3434% of paid-up capital. The sale is small, and SBI MF is still a significant institutional holder, but the move points to mild profit-taking or rebalancing.

Positives 1
  • Subsidiary merger moves toward approval Sep 24

    The NCLT Mumbai Bench has directed Privi to hold a virtual equity shareholders' meeting on October 27, 2026, to approve the amalgamation of two subsidiaries. If approved, the merger could simplify the group structure and cut compliance and administrative costs.

Neutral 1
  • Anand Rathi investor meet, Mumbai Sep 17

    Privi held an investor conference in Mumbai on September 22, 2026, organised by Anand Rathi Institutional Equities. The company said only publicly available information would be discussed, so no new disclosures are expected from it.

TL;DR: Recent news on Privi Speciality is mostly procedural, with no reported changes to earnings, margins or demand in this period. The subsidiary amalgamation is the most meaningful item because it signals corporate simplification, and continued institutional outreach supports the company's visibility. SBI MF's small stake reduction is a minor sentiment negative, though its holding is still above 7%. Overall the trend is stable, and the October 27, 2026 shareholder vote and the next quarterly results are the key upcoming triggers.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
409
455
404
484
464
533
491
614
559
679
605
722
666
Expenses
354
366
314
393
370
423
378
481
427
497
453
541
514
Operating Profit
55
89
90
91
94
110
113
133
132
182
151
180
152
OPM %
13%
20%
22%
19%
20%
21%
23%
22%
24%
27%
25%
25%
23%
Other Income
6
7
6
8
3
4
2
15
9
0
7
4
15
Interest
24
25
24
25
22
22
22
23
24
21
19
18
17
Depreciation
31
31
32
30
32
32
32
35
36
36
36
36
37
PBT
6
40
39
44
43
61
61
90
81
125
104
130
113
Tax %
30%
25%
26%
28%
27%
26%
27%
29%
29%
28%
28%
27%
27%
Net Profit
5
30
29
32
31
45
44
64
58
90
75
94
83
EPS in Rs
1.18
7.8
7.36
7.93
8.02
11.42
11.37
17.01
15.84
24.02
19.95
23.96
21.54
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
597
1,024
1,341
1,631
1,277
1,404
1,608
1,752
2,101
2,564
2,671
Expenses
525
894
1,128
1,362
1,067
1,209
1,420
1,423
1,643
1,912
2,005
Operating Profit
72
130
213
268
210
195
188
329
458
651
666
OPM %
12%
13%
16%
16%
16%
14%
12%
19%
22%
25%
25%
Other Income
10
16
14
66
43
38
21
26
20
19
26
Interest
20
24
29
41
24
25
70
102
92
87
75
Depreciation
27
43
47
63
71
75
108
123
132
144
145
PBT
36
79
152
231
158
133
31
130
255
440
472
Tax %
24%
32%
38%
24%
26%
27%
31%
27%
27%
28%
—
Net Profit
27
53
94
176
117
97
21
95
185
317
342
EPS in Rs
7.21
14.19
24.1
45.1
29.9
24.91
5.68
24.27
47.83
83.77
89.47
Div. Payout %
14%
11%
10%
3%
7%
8%
0%
8%
10%
12%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
38
38
39
39
39
39
39
39
39
39
Reserves
406
451
537
702
683
773
790
885
1,064
1,373
Borrowings
321
330
491
569
537
933
1,079
1,008
1,143
1,021
Other Liabilities
174
235
359
294
281
431
483
410
544
736
Total Liabilities
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170
Fixed Assets
388
437
498
725
598
704
1,017
1,034
1,156
1,169
CWIP
24
49
95
40
175
373
100
99
141
314
Investments
1
3
0
1
0
12
7
40
8
54
Other Assets
527
564
833
839
768
1,087
1,268
1,169
1,485
1,633
Total Assets
939
1,053
1,426
1,604
1,540
2,176
2,391
2,343
2,791
3,170
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
17
107
21
247
172
5
49
354
281
550
Investing
80
-81
-139
-206
-242
-321
-133
-180
-294
-358
Financing
-89
-20
122
27
0
333
72
-171
39
-198
Net Cash Flow
7
5
4
68
-69
17
-12
4
26
-6
Free Cash Flow
17
107
46
37
-71
-304
-91
212
-17
230
CFO/OP
49
96
24
120
101
19
33
116
77
102
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
106
82
90
60
68
69
67
72
68
75
Inventory Days
236
132
162
135
170
279
311
245
262
235
Days Payable
115
85
95
55
83
138
114
105
134
150
Cash Conversion Cycle
227
129
157
139
155
209
264
212
197
160
Working Capital Days
31
20
40
45
65
19
16
37
35
54
ROCE %
—
13%
18%
20%
12%
10%
6%
12%
16%
22%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Privi Speciality Chemicals insights

64 extracted metrics + investor summaries across FY10–FY27.

Log in — free

Shareholding Pattern

FIIs1.94%Promot.60.60%Others9.64%DIIs10.08%Public17.74%As ofJun 2026

Documents

Frequently Asked Questions about Privi Speciality Chemicals

What does Privi Speciality Chemicals Ltd do?
Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]
Where is Privi Speciality Chemicals Ltd (PRIVISCL) listed?
Privi Speciality Chemicals Ltd trades as PRIVISCL on the NSE and under code 530117 on the BSE.
Which sector does Privi Speciality Chemicals Ltd belong to?
Privi Speciality Chemicals Ltd is classified under the Chemicals sector, in the Specialty Chemicals industry.
What is the market capitalisation of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd has a market capitalisation of ₹13,905 Cr, which places it in the Mid Cap band.
What is the PE ratio of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd trades at a PE ratio of 39.94, on earnings per share of ₹31.14, against a book value of ₹361.58 per share.
What is the 52-week high and low of Privi Speciality Chemicals Ltd?
Over the last 52 weeks Privi Speciality Chemicals Ltd has traded between ₹2,345.3 and ₹3,785.3.
Does Privi Speciality Chemicals Ltd pay dividends?
Privi Speciality Chemicals Ltd has a dividend yield of 0.28%.
What is the Return on Equity (ROE) of Privi Speciality Chemicals Ltd?
Privi Speciality Chemicals Ltd reported a return on equity of 21.99%. Its debt-to-equity ratio is 0.72.

Company Information

Incorporated in 1985, Privi Speciality Chemicals Ltd (Formerly known as Privi Speciality Ltd.) is primarily engaged in the manufacturing, supply and exports of aroma and fragrance chemicals used in soaps, detergents, shampoos, and other fine fragrances. [1]

Website privi.com
CEO Mr. Mahesh Purshottambhai Babani
Employees 672
Listed 2015-05-08
Face Value ₹ 10
Issued Size 3,90,62,706

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PRIVISCL.md for Privi Speciality Chemicals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List